Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-16

Clinical Trial Update: Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial compares moderate-intensity rosuvastatin with ezetimibe against high-intensity rosuvastatin to evaluate progression of coronary ather…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)
  • Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Coronary Artery Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING